by David Schwartz J.D. CPA | Jul 12, 2012 | All, Formal Regulatory Remedies
In his July 4 address before the Europlace Financial Forum, European Securities and Markets Authority (ESMA) chair, Steven Maijoor, announced that ESMA would be proposing standards implementing regulation of OTC derivatives, central counterparties and trade...
by David Schwartz J.D. CPA | Jun 26, 2012 | All, Formal Regulatory Remedies
The UK’s Treasury has published a white paper setting out how the government intends to implement the recommendations of the Independent Commission on Banking (the Vickers Report). The paper offers further detail on plans to separate retail and investment...
by David Schwartz J.D. CPA | Jun 24, 2012 | All, Formal Regulatory Remedies
The Board of Governors of the Federal Reserve System voted on June 7 to approve proposed rules intended to implement the regulatory capital standards promulgated under “Basel III: A Global Regulatory Framework for More Resilient Banks and Banking Systems.” These...
by David Schwartz J.D. CPA | Jun 21, 2012 | All, Change Overview and Rationale
In a piece published June 14, Peter J. Wallison, Fellow at the American Enterprise Institute, argues against imposing any new regulation on shadow banking markets and firms without without convincing proof they need it. According to Wallison, the calls from regulators...
by David Schwartz J.D. CPA | Jun 19, 2012 | All, Change Overview and Rationale, Formal Regulatory Remedies, Procedural Changes
OTC derivatives legislation and clearing reforms understandably have European and US market participants scratching their heads about what this “sea of change” has in store for them and the future of OTC markets. David Felsenthal, a partner at Clifford...
